Status and phase
Conditions
Treatments
About
The primary objective of this study is to determine which treatment will be more effective to reduce left ventricular mass in hypertensive patients with left ventricular hypertrophy comparing aliskiren and eplerenone.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Male or female ≧ 20 years of age Clinical diagnosis of hypertension Patients who are able to provide written informed consent
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
100 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal